Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile
Ilaria Del Giudice(Sapienza University of Rome), Robin Foà(Sapienza University of Rome), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Elisa Tammiso(Arcispedale Sant'Anna), Francesca Romana Mauro(Sapienza University of Rome), Elena Saccenti(University of Ferrara), Sara Raponi(Sapienza University of Rome), Simona Tavolaro(Policlinico Umberto I), Gian Matteo Rigolin, M. Nanni(Centro de Investigaciones Cardiovasculares), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alfonso Piciocchi(Fondazione Gimema Onlus), Marco Filetti(Agostino Gemelli University Polyclinic), Anna Guarini(Sapienza University of Rome), Raúl Rabadán(Columbia University Irving Medical Center), Antonio Cuneo(Arcispedale Sant'Anna), Luciana Cafforio(Center for Genomic Science), Eleonora Volta(Arcispedale Sant'Anna), Mykola Bordyuh(Columbia University), Massimo Negrini(University of Ferrara), Jiguang Wang(Hong Kong University of Science and Technology), M Marinelli(Policlinico Umberto I), Caterina Ilari(Sapienza University of Rome), Antonella Bardi(University of Ferrara)
Cited by 4
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644